Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Farfield Scientific was a specialized life sciences instrumentation company that pioneered Dual Polarization Interferometry (DPI) for molecular analysis. The company's flagship AnaLight platform enabled researchers to observe real-time structural changes in proteins and other biomolecules at the sub-angstrom level. This technology provided critical insights into molecular orientation, density, and thickness, supporting drug discovery and fundamental biological research. By offering structural data alongside kinetic information, Farfield's tools provided a unique advantage over traditional label-free detection methods. The company was acquired by Biolin Scientific in 2008, integrating its technology into a broader portfolio of surface science instruments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Farfield Scientific.